Q4 2024 Holdings
Filed 2025-02-14 | 14 holdings | $394.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $115.5M | 8,118,592 | 29.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $66.7M | 1,436,878 | 16.9% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $50.8M | 1,525,730 | 12.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $29.7M | 2,692,388 | 7.5% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $23.6M | 1,435,130 | 6.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $22.5M | 2,995,932 | 5.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $20.6M | 626,280 | 5.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.6M | 3,052,538 | 4.2% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $13.8M | 1,767,982 | 3.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $12.4M | 1,011,155 | 3.2% |
| Merus N V | COM | N5749R100 | $10.7M | 255,000 | 2.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $5.5M | 752,167 | 1.4% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $5.2M | 7,429,687 | 1.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.1M | 184,826 | 0.3% |